Capital Directions Investment Advisors’s DUSA PHARMACEUTICALS INC DUSA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-366
Closed -$12K 255
2021
Q3
$12K Buy
366
+89
+32% +$2.92K ﹤0.01% 232
2021
Q2
$10K Buy
+277
New +$10K ﹤0.01% 211

Capital Directions Investment Advisors's DUSA Position: Q4 2021 in Review

Capital Directions Investment Advisors sold out of DUSA PHARMACEUTICALS INC (DUSA) in Q4 2021, closing a stake of 366 shares — an estimated $12K sold.

Capital Directions Investment Advisors first reported a position in DUSA in Q2 2021 and held it in 2 quarters. The position peaked at $12K in Q3 2021. 0 funds tracked by Wall St. Rank hold DUSA as of Q4 2021.

  • Capital Directions Investment Advisors reported no remaining DUSA PHARMACEUTICALS INC position as of Q4 2021 after selling out during the quarter.
  • Capital Directions Investment Advisors sold 366 DUSA PHARMACEUTICALS INC shares in Q4 2021, an estimated $12K.
  • Capital Directions Investment Advisors first reported a position in DUSA PHARMACEUTICALS INC in Q2 2021 and held it in 2 quarters.
  • Capital Directions Investment Advisors's DUSA PHARMACEUTICALS INC position peaked at $12K in Q3 2021.
  • 0 funds tracked by Wall St. Rank held DUSA PHARMACEUTICALS INC as of Q4 2021.

Based on Capital Directions Investment Advisors's 13F filing for Q4 2021, filed 22 Feb 2022.